Cargando…
Two Panels of Steroid Receptor Luciferase Reporter Cell Lines for Compound Profiling
Steroid hormone receptors represent a major target in drug discovery. As ligand inducible transcription factors, their activity can be modulated by small lipophilic molecules. Here we describe two panels of potent and selective luciferase reporter cell lines based on cells with low endogenous steroi...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bentham Science Publishers Ltd
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3234597/ https://www.ncbi.nlm.nih.gov/pubmed/21375502 http://dx.doi.org/10.2174/138620711795222446 |
_version_ | 1782218526903238656 |
---|---|
author | Sedlák, David Paguio, Aileen Bartůněk, Petr |
author_facet | Sedlák, David Paguio, Aileen Bartůněk, Petr |
author_sort | Sedlák, David |
collection | PubMed |
description | Steroid hormone receptors represent a major target in drug discovery. As ligand inducible transcription factors, their activity can be modulated by small lipophilic molecules. Here we describe two panels of potent and selective luciferase reporter cell lines based on cells with low endogenous steroid receptor activity (U2OS). The panels contain reporter cell lines for estrogen receptors α and β, androgen, glucocorticoid, mineralocorticoid, and progesterone receptors. In the first panel, the activation of either synthetic, steroid response elements containing promoter or viral promoter is mediated by full-length steroid receptors. The second panel is based on the expression of the chimeric receptor, which was created by the replacement of the N-terminal part of the molecule by Gal4 DBD and that binds to multiple UAS sites in the reporter promoter. Both panels were extensively characterized by profiling 28 ligands in dose response manner in agonist and antagonist mode. We have analyzed and compared the responses to tested ligands from both panels and concluded that in general both systems generated similar qualitative response in terms of potency, efficacy, partial agonism/antagonism, mixed agonistic/antagonistic profiles and the rank of potencies was well conserved between both panels. However, we have also identified some artifacts introduced by the Gal4/LBD reporter assays in contrast to their full-length receptor reporter counterparts. Keeping in mind the advantages and drawbacks of each reporter format, these cell lines represent powerful and selective tools for profiling large compound libraries (HTS) and for detailed study of mechanisms by which compounds exert their biological effects. |
format | Online Article Text |
id | pubmed-3234597 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2011 |
publisher | Bentham Science Publishers Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-32345972011-12-29 Two Panels of Steroid Receptor Luciferase Reporter Cell Lines for Compound Profiling Sedlák, David Paguio, Aileen Bartůněk, Petr Comb Chem High Throughput Screen Article Steroid hormone receptors represent a major target in drug discovery. As ligand inducible transcription factors, their activity can be modulated by small lipophilic molecules. Here we describe two panels of potent and selective luciferase reporter cell lines based on cells with low endogenous steroid receptor activity (U2OS). The panels contain reporter cell lines for estrogen receptors α and β, androgen, glucocorticoid, mineralocorticoid, and progesterone receptors. In the first panel, the activation of either synthetic, steroid response elements containing promoter or viral promoter is mediated by full-length steroid receptors. The second panel is based on the expression of the chimeric receptor, which was created by the replacement of the N-terminal part of the molecule by Gal4 DBD and that binds to multiple UAS sites in the reporter promoter. Both panels were extensively characterized by profiling 28 ligands in dose response manner in agonist and antagonist mode. We have analyzed and compared the responses to tested ligands from both panels and concluded that in general both systems generated similar qualitative response in terms of potency, efficacy, partial agonism/antagonism, mixed agonistic/antagonistic profiles and the rank of potencies was well conserved between both panels. However, we have also identified some artifacts introduced by the Gal4/LBD reporter assays in contrast to their full-length receptor reporter counterparts. Keeping in mind the advantages and drawbacks of each reporter format, these cell lines represent powerful and selective tools for profiling large compound libraries (HTS) and for detailed study of mechanisms by which compounds exert their biological effects. Bentham Science Publishers Ltd 2011-05 /pmc/articles/PMC3234597/ /pubmed/21375502 http://dx.doi.org/10.2174/138620711795222446 Text en © 2011 Bentham Science Publishers Ltd. http://creativecommons.org/licenses/by/2.5/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.5/), which permits unrestrictive use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Article Sedlák, David Paguio, Aileen Bartůněk, Petr Two Panels of Steroid Receptor Luciferase Reporter Cell Lines for Compound Profiling |
title | Two Panels of Steroid Receptor Luciferase Reporter Cell Lines for Compound Profiling |
title_full | Two Panels of Steroid Receptor Luciferase Reporter Cell Lines for Compound Profiling |
title_fullStr | Two Panels of Steroid Receptor Luciferase Reporter Cell Lines for Compound Profiling |
title_full_unstemmed | Two Panels of Steroid Receptor Luciferase Reporter Cell Lines for Compound Profiling |
title_short | Two Panels of Steroid Receptor Luciferase Reporter Cell Lines for Compound Profiling |
title_sort | two panels of steroid receptor luciferase reporter cell lines for compound profiling |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3234597/ https://www.ncbi.nlm.nih.gov/pubmed/21375502 http://dx.doi.org/10.2174/138620711795222446 |
work_keys_str_mv | AT sedlakdavid twopanelsofsteroidreceptorluciferasereportercelllinesforcompoundprofiling AT paguioaileen twopanelsofsteroidreceptorluciferasereportercelllinesforcompoundprofiling AT bartunekpetr twopanelsofsteroidreceptorluciferasereportercelllinesforcompoundprofiling |